Search

Biorisk management is defined as coordinated activities to direct and control an organisation with regard to biological risk or “biorisk”. These activities include both administrative controls as well as laboratory procedures and practices.

Together with the public health authorities in the Nordic countries including Åland, the Faroe Islands and Greenland, the authority has gathered knowledge and experience from working with the pandemic. The report will be an important basis for continued updates of pandemic plans and for increased

This is a report on sexual and reproductive health and rights (SRHR) and STI prevention among young people and young adults (16-29 years) living with HIV in Sweden. The report is based on a survey conducted in 2018. The starting point is the Public Health Agency of Sweden’s work on the national HIV

EUPAP

The professional use of Class 1 and 2 plant protection products and Class 1 biocide products within Swedish Public Health Agency areas of responsibility are in the form of regulated professions, consequently Swedish legislation regulates what is required for such use.

The 21 regions and 290 municipalities in Sweden are political bodies and most of the welfare services that impact citizens’ lifelong health fall under their remit, such as healthcare, childcare, schools, social service, elderly care and support to people with disabilities, some emergency services…

The report presents results from a pilot test of Tailoring Immunization Programmes (TIP), a method developed by WHO/Europe to identify barriers and motivating factors to MMR vaccination in communities with low coverage in Sweden.

Monitoring sales of antibiotics and occurrence of resistant bacteria routinely and consistently makes it possible to analyse trends and identify changes that require quick action, as well as evaluate the effect of interventions.

The Public Health Agency of Sweden’s website uses cookies. Cookies are small text files that are created and stored on the computer or mobile device you are using to visit our website. These text files are not malicious and they do not contain any program code. We use cookies to improve our website…

The report presents different models for making available both new antibiotics and old antibiotics where national availability is insufficient. The models should also minimise the risk of resistance development while enabling the best possible care for patients with infections caused by